Read our previous insight-driven newsletters covering business, finance, economics and tech.
Plus: Will DoorDash go from a 2025 feast to a 2026 famine?
Plus: Buffer ETFs are popular, but why?
Plus: Asset managers go to Washington with election contract ETFs.
Plus: Moderna scores another shot to bring its flu jab to market.
Plus, a case against buffer ETFs for most, and a case for some.
Plus: Alibaba’s success in the AI wars is not a matter of if, but Qwen.
Plus: A startup wants to bury nuclear reactors deep under the earth.
Plus: Advisors are adding a little punk rock to their practices.